Three new cardiac glycosides strophanthidin-3-O-a-L-rhamnopyranosyl-(1/4)-6-deoxy-b-Dallopyranoside (1), 5bH-16b-acetylkamaloside (2), and mansonin-19-carboxylic acid (3) along with seven known steroids including five cardiac glycosides were isolated from the methanol extracts of Streblus asper Lour. roots. The structures of these compounds were established by spectroscopic analyses. The cytotoxicities of crude extracts and all the isolated compounds were evaluated against four human cancer cell lines (HL60, A549, AZ521, and SKBR3). Furthermore, the selective index (SI) of each compound was measured by the ratio of cytotoxic effect on a normal cell line (WI38) to the cytotoxic effect on cancer cell line (A549). The results suggested that cardiac glycosides (2, 4, and 6-8) exhibited significant cytotoxicities with IC 50 values from 0.01 to 3.77 mM as well as high selective index for WI38/ A549 (SI 1.50-24.26), and they displayed superior selectivities when compared with the reference cisplatin (SI 1.09). Preliminary structure-activity relationships (SARs) were also discussed regarding the type of C-10 group in the cardiac glycosides being a crucial factor in determining the cytotoxic activities and regarding the sugar moieties having much less of an active role than the type of C-10 group. In addition, the melanogenesis-inhibitory abilities of these compounds were also evaluated. Cardiac 
Introduction
The small trees of Streblus asper Lour. (Moraceae) are mainly distributed in tropical regions including India, Sri Lanka, Malaysia, Thailand, Vietnam, and South-west China.
1,2 S. asper is traditionally used in Ayurveda and in the medicine of Chinese minorities for the treatment of different ailments.
1,2 In Ayurveda, the roots of S. asper are used to treat unhealthy ulcers, sinuses, epilepsy, and obesity, and they are applied locally as an antidote to snake bite. 1 In current pharmacologic research, S. asper has exhibited antilarial, 3, 4 antimicrobial, 5 antimalarial, 6 anti-HBV, 7, 8 antidiabetic, 9 cytotoxic, and antineoplastic activities. [10] [11] [12] The chemical constituents of S. asper including avo-noids, 7, 13 volatile oils, 14 phenolic acids, 4 fatty acids, 15 phenylpropanoids, 7, 8, 16, 17 and cardiac glycosides [18] [19] [20] [21] have been extensively studied. Numerous cardiac glycosides have also been discovered from the roots of this plant.
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In this study, three new cardiac glycosides (1-3) were discovered through phytochemical research on the roots of S. asper. The structures of the isolated compounds were characterized by spectroscopic analyses and compared with the results of the literature data. The cytotoxicities of the crude extracts and isolated compounds were evaluated against HL60, A549, AZ521, and SKBR3 human cancer cell lines as well as WI38 human normal cell line for obtaining the selective index (SI). Combining the structural characteristics, the structure-activity relationships (SARs) of potential bioactive cardiac glycosides were also evaluated. Bufalin is a cardiac aglycone, which belongs to bufanolide, and it can stimulate melanin synthesis in B16F10. 22 Thus, cardiac glycosides (3) (4) (5) (6) (7) (8) having aglycones belonging to cardenolides were selected for the evaluation of their ability to stimulate melanin synthesis in a-melanocyte (a-MSH)-stimulated B16F10 cells. It was interesting that 3-8 showed melanogenesis-inhibitory abilities. Hence, we chose four key melanogenesis-related proteins to further explore the mechanisms of melanogenesis-inhibitory activities using western blot.
Results and discussion
2.1 Cytotoxic and melanogenesis-inhibitory activities of the extracts of S. asper roots Dried S. asper roots were extracted with n-hexane rst and then, the defatted residue was extracted with MeOH. The methanol extract was successively fractionated into EtOAc, n-BuOH and H 2 O fractions. Both the extracts and fractions were evaluated for cytotoxic activities against four human cancer cell lines (HL60, A549, AZ521, and SKBR3) and inhibitory potentials on the production of melanin in a-MSH-activated B16F10 cells. As shown in Table 1 , the EtOAc and n-BuOH fractions exhibited strong activities and IC 50 values ranging from 0.05 to 1.79 mg mL À1 , which were higher than those of the reference cisplatin (IC 50 1.14-5.60 mg mL À1 ). As shown in Fig. 1 , the n-hexane extract and EtOAc fraction inhibited melanin production signicantly by 36.6% and 8.3% (MC), respectively, at a high concentration of 100 mg mL
À1
; moreover, the n-hexane extract and EtOAc fraction displayed values of 86.7% and 86.6% (MC) at a low concentration of 10 mg mL À1 along with weak toxicities (CV: 86.8% and 91.4%, respectively), which were similar to those of the reference arbutin (MC: 87.1%, CV: 96.5%). Herein, the EtOAc and n-BuOH fractions, which exhibited reasonable cytotoxicities and melanogenesis inhibition, were chosen for further investigation of their constituents in this study.
Identication and structure elucidation
The phytochemical results for EtOAc and n-BuOH fractions were obtained via column chromatography with the use of silica gel (Sephadex LH-20, ODS) and semipreparative RP-18 HPLC, which led to the isolation of ten compounds. Three new cardiac glycosides strophanthidin- suggested that 1 had two 6-deoxysugars. Analyses of 1D-NMR and 2D-NMR data revealed that the sugar moieties were 6-deoxy-b-D-allose and a-L-rhamnose; 27,28 their absolute cong-urations were determined by acid hydrolysis, and the results were compared with those of the standard substances. The HMBC correlations between H-1 0 and C-3 as well as H-1 00 and C-4 0 were used to establish the positions of the sugar units.
Accordingly, compound 1 was identied as strophanthidin
Compound 2 was obtained as white powder. It was assigned the molecular formula C 33 16 HMBC correlation between H-1 0 and C-3 was used to establish the position of the sugar unit. The stereo structure was further conrmed by 1D-NMR and 2D-NMR. The combined was replaced with an aldehyde group at C-10, and it was determined to have the strophanthidinic acid skeleton by 1D-NMR and 2D-NMR data (Table 2 ).
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The resonance Fig. 1 Melanin content and cell viability were determined for melanogenesis-inhibitory activities of S. asper in B16F10 cell lines, which with and without a-MSH treatment were used as negative controls, whereas arbutin was used as the positive control. *P < 0.05, **P < 0.01, ***P < 0.001 compared with a-MSH model group in three separate experiments. H-NMR and 13 C-NMR spectroscopic data of compounds COSY, HSQC, and HMBC data revealed that the sugar moiety was 6-deoxy-2,3-dimethoxyl-b-D-gluopyranoside. 10 HMBC correlation between H-1 0 and C-3 was used to establish the position of the sugar unit. The combined results showed that compound 3 was mansonin-19-carboxylic acid.
Cytotoxic activities of compounds
The cytotoxic activities of ten compounds, 1-10, and the reference chemotherapeutic drug, cisplatin, against human cell lines (HL60, A549, AZ521, SKBR3, and WI38) were evaluated using MTT assays ( C-10 substituent in these cardiac glycosides was a crucial factor in determining the cytotoxic activity. 32, 33 However, the results showed that the methyl group linked to C-10 seemed to have superior selectivity than the aldehyde group, and the aldehyde group linked to C-10 seemed to have better selectivity than the carboxyl group, which was evidenced from the comparisons between 5 (SI 1.00) and 7 (SI 15.00), 3 (SI 0.66) and 4 (SI 1.50), and 6 (SI 8.00) and 8 (SI 24.26). In addition, OH-5 and OCOCH 3 -16 were the potential cytotoxic groups compared with these compounds, and the results were supported by the results given in the literature. 34, 35 Furthermore, observation of two pairs of related compounds 5/6, and 7/8 indicated that cardiac glycosides displayed weaker cytotoxicities with an increase in the number of sugar units. The sugar moiety is another factor while determining cytotoxic activity, 34 but the sugar moieties were less active than C-10 groups.
Melanogenesis-inhibitory activities of compounds
To identify the active constituents, compounds (3) (4) (5) (6) (7) (8) from the EtOAc fraction were investigated for anti-melanogenic effects, with arbutin as positive control. The cytotoxic activities of these compounds against B16F10 cells were also determined by MTT assays. To assess the risk/benet ratio of each compound, relative activities vs. toxicities were calculated by dividing the melanin content (MC, %), by the cell viability (CV, %), and this was expressed as an activity-to-cytotoxicity ratio (A/C ratio) for each compound. 36 As shown in Table 4 , the compounds were treated with three concentrations (100 mM, 30 mM, and 10 mM). Cardiac glycosides 3 and 6-8 inhibited melanin production in a dose-dependent manner. 3 proved to be the most potent melanogenesis inhibitor (MC: 26.22%) with weak cytotoxicity (CV: 77.94%) by exhibiting minimum A/C ratio (0.34) at a concentration of 100 mM, and its inhibitory activity was stronger than that of the reference arbutin (MC: 82.5%, CV: 107.60%, and A/C ratio 0.77 at 100 mM). 6-8 in this study proved to be low-risk melanogenesis inhibitors (MC: 61.36-74.90% and CV: 90.54-111.70%) by exhibiting small A/C ratios (0.65-0.80) at a concentration of 100 mM. Conversely, 4 and 5 did not suppress melanin production (MC: 94.65% and 94.47%, respectively) even at a concentration of 100 mM. These results indicated that 3 and 6-8 were responsible for the melanogenesis-inhibitory activities of the EtOAc fraction.
Western blot analysis of melanogenesis-related proteins
Depigmentation can be achieved by regulating the transcriptions and activities of tyrosinase, tyrosinase-related protein-1 (TRP-1) and tyrosinase-related protein-2 (TRP-2). 37 Tyrosinase, a rate-limiting enzyme, catalyzes the hydroxylation of L-tyrosine to l-(3,4-dihydroxyphenyl)-alanine (L-DOPA) and the oxidation of L-DOPA to L-DOPA quinone. 38 TRP-1 catalyzes the oxidation of 5,6-dihydroxyindole-2-carboxylic acid (DHICA), and TRP-2 functions as DOPAchrome tautomerase. 39 Transcription for the expression of these enzymes is regulated by the microphthalmia transcription factor (MITF). 38 To clarify the mechanism involved in melanogenesis inhibition by 3, which was the most potent melanogenesis inhibitor at 100 mM (MC: 26.22%, CV: 77.94%, A/C 0.34) in this study, the protein levels of tyrosinase, TRP-1, TRP-2, and MITF were evaluated in B16F10 cells treated with 3 (30 mM and 100 mM) by western blot analysis. As shown in Fig. 4 , the protein levels of TRP-2 and tyrosinase decreased in a dose-dependent manner, whereas those of TRP-1 indicated a slight change. However, the protein levels of MITF treated with 3 at 30 mM were higher compared with those of the control group (the second line), but they were much lower at 100 mM. These results indicated that 3 possessed almost no melanogenesis-inhibitory activity at 30 mM (MC: 89.29%). Although the protein levels of MITF and TRP-1 were higher than those of the control group, tyrosinase, which is a rate-limiting enzyme, showed lower level compared with the control group, and this was in accordance with the changes in the melanin contents at 30 mM and 10 mM. It was inferred that 3 exhibited melanogenesis inhibitory activity on a-MSH-stimulated B16F10 cells by decreasing the expressions of TRP-2 and tyrosinase.
Conclusion
In this study, three new cardiac glycosides strophanthidin-3-O-a-L-rhamnopyranosyl-(1/4)-6-deoxy-b-D-allopyranoside (1), 5bH-16b-acetylkamaloside (2), and mansonin-19-carboxylic acid (3) along with seven known steroids were isolated from the methanol extracts of S. asper roots. The cardiac glycosides 2, 4, and 6-8 indicated potent cytotoxicities and high SI values, and they displayed superior selectivities when compared with the reference cisplatin. SARs were also discussed regarding the type of C-10 groups in the cardiac glycosides and the sugar moieties' effects on cytotoxicity. In addition, the cardiac glycosides 3 and 6-8 displayed moderate inhibition of melanogenesis compared with the reference arbutin. The western blot analysis of melanogenesis-related proteins suggested that 3 could inhibit melanogenesis by suppressing the protein expressions of TRP-2 and tyrosinase. The current study contributes to the understanding of SARs of cytotoxicity and mechanisms of the melanogenesis-inhibitory activities of cardiac glycosides, which will hopefully help develop new potential antitumor and melanogenesis-inhibitory agents.
Experimental

General experimental procedures
IR spectra were acquired on a Bruker Tensor 27 spectrometer in KBr discs. Semipreparative HPLC was operated with an SSC-3461 pump (Senshu Scientic Co., Ltd), an Shimadzu Shodex RI-101 detector (Showa Denko K.K.), an SS-100F Recorder using a Capcell pak AQ column (250 Â 10 mm, 5 mm, Shiseido) and a Pegasil SP 100 column (250 Â 10 mm, 5 mm, Senshu Scientic Co., Ltd). Semipreparative HPLC was conducted on an SSC-6600 Gradient Controller (Senshu Scientic Co., Ltd) equipped with an SSC-3461 pump (Senshu Scientic Co., Ltd) and a Shodex Model 55 ELSD detector (Sedere, Franc.) with a Capcell pak C18 column (250 Â 4.6 mm, 5 mM, Shiseido). HR-ESI-MS spectra were obtained using a Bruker Micro TOF model mass spectrometer. 1D and 2D NMR experiments were carried out on JNM-AL400 and JNM-ECX400 spectrometers (JEOL, Ltd) using tetramethylsilane (TMS) as internal standard. Column chromatography separations were performed on silica gel (100-200 mesh and 200-300 mesh, Merck & Co., Inc.) and ODS gel (50 mm, Fuji Silysia Chemical, Ltd.). TLC was carried out on silica gel GF254 (Millipore, Ltd.). Spots were visualized under UV light (254 and 365 nm) and sprayed with Keddle reagent and vanillin/H 2 SO 4 (1 : 100, w/v) (the former reagent showed red spots and the latter reagent showed green spots); this was followed by heating if the compounds were cardiac glycosides. CH 3 OH used in the preparative HPLC procedure was of HPLC grade, and the other solvents were of analytical grade (Kanto Chemical Co., Inc.).
Plant materials
The roots of S. asper were collected from Chiang Mai, Thailand in October of 2015. The roots were identied by Prof. Dr Jiradej Manosroi (Manose Health and Beauty Research Center, Chiang Mai, Thailand). A voucher specimen (No. 20150060) was deposited in the Department of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing, China.
Extraction and isolation
The roots (2.1 kg) of S. asper were defatted with n-hexane, and the residue was extracted with MeOH by heat reuxing. The
MeOH extract (140.7 g) was suspended in H 2 O, and it was successively partitioned into EtOAc (22.7 g), n-BuOH (32.0 g) and H 2 O (55.1 g) fractions. The n-BuOH part (18.0 g) was subjected to column chromatography (CC) on Diaion HP-20 (900 g), and it was eluted with H 2 O : MeOH (100 : 0 / 0 : 100, each 0.2 L) to give 6 fractions (B1 to B6); then, compound 6 (178.8 mg) was obtained by recrystallization. B5 (2728.4 mg) was applied to silica gel using gradient elution of CHCl 3 : MeOH (90 : 10 to 87 : 13, v/v) to obtain 4 fractions (B5-1 to B5-4). Then, B5-1 (119.8 mg) was subjected to preparative HPLC [mobile phase of MeOH : H 2 O (60 : 40, v/v) at a ow rate of 2.0 mL min À1 with
RI detection] to yield 8 (3.2 mg) on a C18 column (Pegasil ODS SP100, t R ¼ 65.6 min). B5-2 (253.4 mg) was subjected to ODS CC, and it was eluted with H 2 O : MeOH (50 : 50, v/v) to yield three fractions (B5-2-1 to B5-2-3). B5-2-1 (107.1 mg) was subjected to silica gel CC, and it was eluted with CHCl 3 : MeOH (15 : 1, v/v) to yield B5-2-1-1 to B5-2-1-4. B5-2-1-4 (62.5 mg) was subjected to preparative HPLC to obtain B5-2-1-4-1 (21.9 mg, t R ¼ 31.5-34.5 min, mobile phase of MeOH : H 2 O (50 : 50, v/v) at a ow rate of 2.0 mL min À1 with UV detection, l ¼ 220 nm). Then, B5-2-1-4-1 was subjected to silica gel CC, and it was eluted with CHCl 3 : MeOH (80 : 10, v/v) to yield compound 1 (9.8 mg). The EtOAc part (22.0 g) was subjected to column chromatography on silica gel (700 g), and it was eluted with n-hexane: EtOAc (100 : 0 to 0 : 100, v/v) and EtOAc : MeOH (100 : 0 to 0 : 100, v/v, each 0.5 L) to give 6 fractions (E1 to E6, monitored by TLC). E2 (364.7 mg) yielded compound 9 (0.9 mg) by recrystallization. E4 (1290. Table 2 ). , and B16F10 were maintained in adhesion on Petri dishes with Dulbecco's Modied Eagle's Medium (DMEM, Sigma-Aldrich, Japan) supplemented with 10% heatinactivated fetal bovine serum (FBS, GIBCO), penicillin-streptomycin (100 U mL À1 , GIBCO). HL60 was suspended in RPMI medium 1640 with 10% FBS, penicillin-streptomycin (100 U mL À1 ), and WI38 was maintained in adhesion on Petri dishes with Minimum Essential Medium (MEM, Sigma-Aldrich, Japan) with 10% FBS, penicillin-streptomycin (100 U mL À1 ). Cells were grown at 37 C in an atmosphere of 5% CO 2, 95% air and >95% humidity, and those that passaged three or more times were used for each test. HL60, a oating cell, was recovered with the medium from the dish, and other adherent cells were washed with phosphate buffer saline (PBS) and recovered by the action of 0.05% trypsin-EDTA (GIBCO). The collected cells were centrifuged at 800 rpm at 4 C for 5 min. Aer separating and removing the supernatant liquid, an appropriate amount of medium was added and pipetted to prepare a cell suspension. The cell suspension (10 mL) was taken, the number of cells in the corning chamber were counted, and an appropriate amount of the medium was added in each experiment to obtain the appropriate cell density. 
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The B16F10 cells were cultured at a density of 5 Â 10 4 cells per well in 24-well plates for 24 h. Then, 0.10 mM a-MSH (SigmaAldrich, Japan) and the tested compounds were added at varying concentrations, and the cells were incubated for additional 48 h. The cells were washed three times with PBS and centrifuged at 95 000 g for 5 min. The harvested cells were dissolved in 100 mL of 2 N NaOH (Wako Pure Chemical Industries) and 10% dimethyl sulfoxide (DMSO, Sigma-Aldrich, Japan) solution, maintained at 80 C for 0.5 h, and mixed to solubilize the melanin. The absorbance value of the supernatant was measured at 405 nm using a microplate reader. The calculation formula of the melanin content is as follows: MC% ¼ [(Abs sample À Abs blank )/(Abs control À Abs blank )] Â 100%. The calculation formula of activity-to-cytotoxicity ratio is as follows: A/C ¼ (MC%)/(CV%). The statistical signicance of the differences between control and treatment groups was analyzed using the program GraphPad Prism 5. The melanogenesisinhibitory agent arbutin was used as the reference compound. 4.4.4 Western blot analysis. The B16F10 cells were incubated with various concentrations of 3 (30 mM and 100 mM), and they were subsequently treated with 0.10 mM a-MSH for 48 h. Aer incubation, the cells were harvested and washed twice with ice-cold PBS. The cells were lysed in lysis buffer (2% sodium dodecyl sulfate, 50 mM Tris-HCl, pH 7.2, 10% glycerol, 2% 2-sulfanylethanol). The cell lysates were centrifuged at 18 650 g at 4 C for 10 min, and the supernatant concentration was determined using the Enhanced BCA Protein Assay Kit (Beyotime, Nanjing, P. R. China). Aliquots of the lysates (30 mg protein) were separated by electrophoresis on 10% sodium dodecyl sulfatepolyacrylamide gel and transferred to a polyvinylidene uoride membrane in glycine transfer buffer [25 mM Tris-HCl, 192 mM glycine, and 20% MeOH (v/v)]. The nonspecic sites were blocked with 5% non-fat skim milk in Tris-buffered saline (TBS)-Tween 20 solution. The membrane was incubated with primary antibodies against MITF, tyrosinase, TRP-1, TRP-2, and b-actin, and it was then incubated with a secondary antibody (1 : 5000; Biogot
